CL
TGTX icon

Choreo LLC’s TG Therapeutics TGTX Stock Holding History

Choreo LLC’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Buy
10,427
+817
+9% +$33.4K 0.01% 915
2026
Q1 		$319K Buy
9,610
+1,677
+21% +$50K ﹤0.01% 1212
2025
Q4 		$236K Sell
7,933
-519
-6% -$16.9K ﹤0.01% 1361
2025
Q3 		$305K Sell
8,452
-209
-2% -$6.88K ﹤0.01% 1215
2025
Q2 		$312K Buy
8,661
+114
+1% +$4.24K ﹤0.01% 1148
2025
Q1 		$337K Buy
8,547
+602
+8% +$20.3K 0.01% 1028
2024
Q4 		$247K Buy
+7,945
New +$228K ﹤0.01% 1293

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Choreo LLC's TGTX Position: Q2 2026 in Review

Choreo LLC increased its TG Therapeutics (TGTX) stake by 8.5% in Q2 2026, buying an estimated $33.4K and bringing the position to 10,427 shares worth $573K. The position accounts for 0.01% of the portfolio, ranked #915.

Choreo LLC first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Choreo LLC held 10,427 shares of TG Therapeutics worth $573K as of Q2 2026.
  • Choreo LLC bought 817 TG Therapeutics shares in Q2 2026, an estimated $33.4K.
  • TG Therapeutics made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #915 holding.
  • Choreo LLC first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.